Genialis, Inc.
Biotechnology company · Boston, Massachusetts, United States
Genialis, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. It has reported private securities offerings to the US SEC, most recently $700,000 sold in a notice filed in 2025.
Profile compiled from public records. Is this your company? Request a correction or update
Genialis at a glance
Typebiotechnology company
HeadquartersBoston, Massachusetts, United States
SEC CIK1948756
What does Genialis do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $700,000 sold (2025).
Frequently asked questions about Genialis
Where is Genialis headquartered?
Genialis, Inc. is headquartered in Boston, Massachusetts, United States.
What does Genialis do?
Genialis, Inc. is a biotechnology company.
Similar companies
- Syntis Bio, Inc.Boston, Massachusetts, United States
- Strand Therapeutics Inc.Boston, Massachusetts, United States
- Pear Therapeutics, Inc.Boston, Massachusetts, United States
- Aura Biosciences, Inc.Boston, Massachusetts, United States
- Holobiome, Inc.Boston, Massachusetts, United States
- Leuko Labs, Inc.Boston, Massachusetts, United States
- Compass Therapeutics, Inc.Boston, Massachusetts, United States
- Odyssey Therapeutics, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences